David is a senior fellow and the director of NORC’s Public Health Analytics Program. He currently specializes in developing surveillance assets based on secondary data sources, health economics, and comparative effectiveness evaluations. David is an internationally recognized expert in visual disorders, viral hepatitis, and the use of secondary EHR and administrative claims data to improve surveillance, cost-effectiveness, and econometric estimates. David brings over 25 years of experience in public health research, practice, and policy, and is a first, senior or contributing author on more than 75 peer-reviewed publications. In 2015, David founded NORC’s Public Health Analytics Program, which is devoted to using quantitative data sources to answer questions of public health importance.

David is the Principal Investigator of the CDC’s Vision and Eye Health Surveillance System (VEHSS), a second project to develop state and county small area estimates of hearing loss, and a third National Institute of Aging R01 Grant to develop a surveillance system of diagnosed Alzheimer’s Dementia and Alzheimer’s Related Dementias. In other recent work, David worked with the CDC’s Vision Health Initiative to estimate the economic burden of vision loss and blindness in the United States. He has worked with CDC partners such as the Division of Injury Prevention and the Division of Viral Hepatitis to develop randomized experimental trials to estimate the effectiveness and cost-effectiveness of public health efforts to prevent falls and to increase testing for hepatitis C. David is also interested in health communication and has worked with CDC Foundation to create an interactive falls risk screening tool and a fall prevention planning tool. 

Prior to joining NORC in 2011, David was a Senior Research Economist at RTI where he led efforts to develop epidemiological forecasting and cost-effectiveness models for vision disorders, hepatitis A, B, and C. His work was used to support the adoption of universal hepatitis A vaccination by the CDC’s Advisory Committee on Immunization Practices, to recommend birth cohort hepatitis C testing by the U.S. Preventive Services Task Force, and by the National Center for Quality Assurance to support a glaucoma screening HEDIS measure. David began his public health career as an ORISE Fellow at CDC where he authored a foundational manuscript on the economic burden of Pelvic Inflammatory Disease and the association of mental health diagnoses and sexually transmitted infections.